Selinexor in Combination With MTX+Ritu to Treat R/R CNSL

NCT05698147 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Lymphoma

Interventions

DRUG: Selinexor
DRUG: Rituximab
DRUG: Methotrexate

Sponsor

Tong Chen, MD

Collaborators

[object Object]